Related references
Note: Only part of the references are listed.Animal models to study bile acid metabolism
Jianing Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia
Cara L. Mack et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course
Mark Deneau et al.
JOURNAL OF PEDIATRICS (2019)
Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics
Amy G. Feldman et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis
Vasiliki Venetsanaki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
Michael Trauner et al.
HEPATOLOGY (2019)
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2019)
OPTN/SRTR 2017 Annual Data Report: Liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis
Dennis D. Black et al.
HEPATOLOGY COMMUNICATIONS (2019)
Human hepatocyte transplantation for liver disease: current status and future perspectives
V. Iansante et al.
PEDIATRIC RESEARCH (2018)
Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids
Claudia Daniela Fuchs et al.
GUT (2018)
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V. Kowdley et al.
HEPATOLOGY (2018)
Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl- channels
Qin Li et al.
HEPATOLOGY (2018)
Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice
Xiaoying Liu et al.
HEPATOLOGY (2018)
Inborn Errors of Bile Acid Metabolism
James E. Heubi et al.
CLINICS IN LIVER DISEASE (2018)
Antifibrotic potential of bone marrow-derived mesenchymal stem cells in biliary atresia mice
Jun Lei et al.
MOLECULAR MEDICINE REPORTS (2018)
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway
Youcai Tang et al.
PLOS ONE (2018)
Bile Acids Activated Receptors Regulate innate immunity
Stefano Fiorucci et al.
FRONTIERS IN IMMUNOLOGY (2018)
Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome
Benjamin L. Shneider et al.
HEPATOLOGY COMMUNICATIONS (2018)
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
Mark R. Deneau et al.
HEPATOLOGY COMMUNICATIONS (2018)
Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice
Xiaoying Liu et al.
JOURNAL OF LIPID RESEARCH (2017)
Hepatic Uptake of Conjugated Bile Acids Is Mediated by Both Sodium Taurocholate Cotransporting Polypeptide and Organic Anion Transporting Polypeptides and Modulated by Intestinal Sensing of Plasma Bile Acid Levels in Mice
Davor Slijepcevic et al.
HEPATOLOGY (2017)
Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
Preeti Pathak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Biliary bile acids in hepatobiliary injury - What is the link?
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2017)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2017)
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
David C. Tully et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
James E. Heubi et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
Vinod S. Hegade et al.
LANCET (2017)
Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PER-eIF2α-ATF4-CHOP pathway
Hong-li Guo et al.
TOXICOLOGY (2017)
4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models
Meichun Zeng et al.
TOXICOLOGY LETTERS (2017)
Ursodeoxycholic acid for cystic fibrosis-related liver disease (Review)
Katharine Cheng et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Bile Acid Recognition by Mouse Heal Bile Acid Binding Protein
Mohsen Badiee et al.
ACS CHEMICAL BIOLOGY (2017)
Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice
Anne S. Henkel et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Pharmacological Inhibition of Apical Sodium-Dependent Bile Acid Transporter Changes Bile Composition and Blocks Progression of Sclerosing Cholangitis in Multidrug Resistance 2 Knockout Mice
Alexander G. Miethke et al.
HEPATOLOGY (2016)
Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease
Youcai Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis
Wendy L. van der Woerd et al.
JOURNAL OF HEPATOLOGY (2016)
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
Anna Baghdasaryan et al.
JOURNAL OF HEPATOLOGY (2016)
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler Disease
Benjamin L. Shneider et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
F. Nevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bipolar and Related Disorders Induced by Sodium 4-Phenylbutyrate in a Male Adolescent with Bile Salt Export Pump Deficiency Disease
Giovanni Vitale et al.
PSYCHIATRY INVESTIGATION (2016)
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
Natalia Gomez-Ospina et al.
NATURE COMMUNICATIONS (2016)
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Eric Lefebvre et al.
PLOS ONE (2016)
Stem Cell Therapies for Treatment of Liver Disease
Clara Nicolas et al.
BIOMEDICINES (2016)
4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress
Tao Luo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2015)
Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate
Emmanuel Gonzales et al.
HEPATOLOGY (2015)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2015)
Improvement of Hepatocyte Transplantation Efficiency in the mdr2-/- Mouse Model by Glyceryl Trinitrate
Lyes Boudechiche et al.
TRANSPLANTATION (2015)
Thematic Review Series: Intestinal Lipid Metabolism: New Developments and Current Insights Intestinal transport and metabolism of bile acids
Paul A. Dawson et al.
JOURNAL OF LIPID RESEARCH (2015)
` Could Stem Cell Therapy be the Cure in Liver Cirrhosis?
Ahmer Irfan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2015)
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia The START Randomized Clinical Trial
Jorge A. Bezerra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Improved Liver Function and Relieved Pruritus after 4-Phenylbutyrate Therapy in a Patient with Progressive Familial Intrahepatic Cholestasis Type 2
Sotaro Naoi et al.
JOURNAL OF PEDIATRICS (2014)
Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1
Yasuhiro Hasegawa et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
The therapeutic potential of chemical chaperones in protein folding diseases
Leonardo Cortez et al.
PRION (2014)
Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis
Vyacheslav U. } Buko et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Genotype-Phenotype Relationships in the Low-Phospholipid-Associated Cholelithiasis Syndrome: A Study of 156 Consecutive Patients
Raoul Poupon et al.
HEPATOLOGY (2013)
The TGR5 receptor mediates bile acid-induced itch and analgesia
Farzad Alemi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress
Huey-Ling Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver
Evita van de Steeg et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Oral Absorbable Fat-soluble Vitamin Formulation in Pediatric Patients With Cholestasis
Yu-Mei Shen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Efficacy of Fat-Soluble Vitamin Supplementation in Infants With Biliary Atresia
Benjamin L. Shneider et al.
PEDIATRICS (2012)
Dual Farnesoid X Receptor/TGR5 Agonist INT-767 Reduces Liver Injury in the Mdr2-/- (Abcb4-/-) Mouse Cholangiopathy Model by Promoting Biliary HCO3- Output
Anna Baghdasaryan et al.
HEPATOLOGY (2011)
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
Sayeepriyadarshini Anakk et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Endoplasmic reticulum stress in liver disease
Harmeet Malhi et al.
JOURNAL OF HEPATOLOGY (2011)
Bone marrow mononuclear stem cell infusion improves biochemical parameters and scintigraphy in infants with biliary atresia
Shilpa Sharma et al.
PEDIATRIC SURGERY INTERNATIONAL (2011)
Folding Defects in P-Type ATP 8B1 Associated with Hereditary Cholestasis Are Ameliorated by 4-Phenylbutyrate
Lieke M. van der Velden et al.
HEPATOLOGY (2010)
Diagnosis and Management of Primary Sclerosing Cholangitis
Roger Chapman et al.
HEPATOLOGY (2010)
Liver disease associated with canalicular transport defects: Current and future therapies
Janneke M. Stapelbroek et al.
JOURNAL OF HEPATOLOGY (2010)
Side Chain Structure Determines Unique Physiologic and Therapeutic Properties of norUrsodeoxycholic Acid in Mdr2-/- Mice
Emina Halilbasic et al.
HEPATOLOGY (2009)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Joana D. Amaral et al.
JOURNAL OF LIPID RESEARCH (2009)
CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury
Nobuyuki Tamaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Liver After Hepatocyte Transplantation for Liver-Based Metabolic Disorders in Children
Alberto Quaglia et al.
CELL TRANSPLANTATION (2008)
New insights on the xenobiotic-sensing nuclear receptors in liver diseases - CAR and PXR-
Satoru Kakizaki et al.
CURRENT DRUG METABOLISM (2008)
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy
A. Floreani et al.
DIGESTIVE AND LIVER DISEASE (2008)
Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis
January T. Salas et al.
GASTROENTEROLOGY (2008)
Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: A case report
A. A. Khan et al.
TRANSPLANTATION PROCEEDINGS (2008)
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion
Romina Fiorotto et al.
GASTROENTEROLOGY (2007)
Liver-specific activities of FGF19 require Klotho beta
Benjamin C. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps
Hisamitsu Hayashi et al.
HEPATOLOGY (2007)
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Verena Keitel et al.
HEPATOLOGY (2007)
Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration
Andreas Geier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes
Umut Oezcan et al.
SCIENCE (2006)
Defects in bile acid biosynthesis - Diagnosis and treatment
Kenneth D. R. Setchell et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Hepatocyte transplantation for liver-based metabolic disorders
Anil Dhawan et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Liver transplantation in a patient with sitosterolemia and cirrhosis
TA Miettinen et al.
GASTROENTEROLOGY (2006)
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice
P Fickert et al.
GASTROENTEROLOGY (2006)
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST alpha-OST beta in cholestasis in humans and rodents
James L. Boyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Novel biotransformation and physiological properties of norursodeoxycholic acid in humans
AF Hofmann et al.
HEPATOLOGY (2005)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans
HU Marschall et al.
GASTROENTEROLOGY (2005)
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats
G Alpini et al.
HEPATOLOGY (2005)
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity
F Chen et al.
GASTROENTEROLOGY (2004)
Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with α-1-antitrypsin deficiency:: A preliminary study
JH Teckman
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Primary sclerosing cholangitis in children: A long-term follow-up study
AE Feldstein et al.
HEPATOLOGY (2003)
Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter
F Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans
LA Woollett et al.
JOURNAL OF LIPID RESEARCH (2003)
Bile salt transporters: Molecular characterization, function, and regulation
M Trauner et al.
PHYSIOLOGICAL REVIEWS (2003)
A G protein-coupled receptor responsive to bile acids
Y Kawamata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)
V Keitel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Identification of membrane-type receptor for bile acids (M-BAR)
T Maruyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats
LF Onuchic et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
MI Prince et al.
GUT (2002)
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
M Ananthanarayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp
LA Denson et al.
GASTROENTEROLOGY (2001)
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
JL Staudinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
W Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
KE Berge et al.
SCIENCE (2000)
Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis
JML De Vree et al.
GASTROENTEROLOGY (2000)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children
MA Gilger et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)
Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z:: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency
JAJ Burrows et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
